Mahoney becomes CEO and president of Boston Scientific
Boston Scientific, a global developer, manufacturer and marketer of medical devices, has named Michael F. Mahoney its new CEO and president. Mahoney succeeds interim CEO William H. (Hank) Kucheman. Mahoney has also been appointed to the Boston Scientific board of directors.
Mahoney has more than 24 years of healthcare experience. He joined Boston Scientific as president in October 2011. For the past year, his responsibilities have focused on the oversight of cardiac rhythm management (CRM), endoscopy (GI and pulmonary) and numerous corporate functions.
Prior to joining Boston Scientific, Mahoney held several senior positions at Johnson & Johnson, most recently worldwide chairman of the medical devices and diagnostics (MD&D) division, overseeing 50,000 employees and seven franchises. Prior to joining Johnson & Johnson, Mahoney served as president and CEO of Global Healthcare Exchange (GHX), a provider of supply chain solutions and services. He began his career at General Electric Medical Systems, where he spent 12 years successfully leading various GE Medical Systems business units in diagnostic imaging, cardiology and healthcare information technology.